Cinar Uğur, Yiğit Ozgür, Alkan Seyhan, Uslu Berna, Topuz Ebru, Unsal Ozlem, Akgül Gökhan, Dadaş Burhan
Department of Otolaryngology, Sişli Etfal Training Hospital, Istanbul, Turkey.
Kulak Burun Bogaz Ihtis Derg. 2003 Jun;10(6):226-30.
We investigated the frequency of hypothyroidism in patients treated with total laryngectomy, hemithyroidectomy-isthmectomy, and postoperative radiotherapy for T3 or T4 larynx cancers.
Twenty-nine male patients (mean age 54 years; range 43 to 72 years) with T3 or T4 larynx cancers were prospectively included in the study. Preoperatively, thyroid function tests were normal in all the patients. Following radiotherapy, serum thyroid-stimulating hormone (sTSH), free triiodothyronine (FT3), and free thyroxine (FT4) levels were measured every three months at least for a year. Detection of an increased level of sTSH together with decreased or normal levels of FT3 and/or FT4 indicated clinical and subclinical hypothyroidism, respectively. The relationship was assessed between hypothyroidism and both age and radiotherapy dosage. Statistical analyses were made with the use of the Student's t- test and Mann-Whitney U-test.
Following radiotherapy, thyroid function tests remained normal in 12 patients (41%), while 12 patients (41%) and five patients (18%) developed subclinical and clinical hypothyroidism, respectively. No significant relationship was found between age and thyroid dysfunction (p>0.05), whereas radiotherapy dosage was found in significant relationship with the development of hypothyroidism (p<0.05).
Due to high rates of subclinical or clinical hypothyroidism following combined therapy, thyroid functions should be closely monitored in patients undergoing laryngectomy for T3 or T4 larynx cancers.
我们调查了接受全喉切除术、半甲状腺切除术-峡部切除术及术后放疗治疗T3或T4期喉癌患者的甲状腺功能减退发生率。
前瞻性纳入29例男性T3或T4期喉癌患者(平均年龄54岁;范围43至72岁)。所有患者术前甲状腺功能检查均正常。放疗后,至少一年内每三个月检测一次血清促甲状腺激素(sTSH)、游离三碘甲状腺原氨酸(FT3)和游离甲状腺素(FT4)水平。sTSH水平升高同时FT3和/或FT4水平降低或正常分别提示临床和亚临床甲状腺功能减退。评估甲状腺功能减退与年龄和放疗剂量之间的关系。采用Student's t检验和Mann-Whitney U检验进行统计分析。
放疗后,12例患者(41%)甲状腺功能检查仍正常,12例患者(41%)发生亚临床甲状腺功能减退,5例患者(18%)发生临床甲状腺功能减退。年龄与甲状腺功能障碍之间未发现显著关系(p>0.05),而放疗剂量与甲状腺功能减退的发生存在显著关系(p<0.05)。
由于联合治疗后亚临床或临床甲状腺功能减退发生率较高,对于接受T3或T4期喉癌喉切除术的患者,应密切监测其甲状腺功能。